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Background: A nearly half of heart failure (HF) patients have preserved left ventricular (LV) ejection fraction (EF) but their mortality rate is 
likely to be identical to that of HF patients with reduced EF. This study aimed to investigate whether cardiac autonomic innervation quantified by 
metaiodobenzylguanidine (MIBG) activity has an independent prognostic value in HF patients with preserved EF as well as those with reduced EF.
Methods: Consecutive 179 HF patients with preserved EF were followed up for 79.6 months after quantification of cardiac MIBG activity as a heart-
to-mediastinum ratio (HMR) and washout kinetics, and data were compared with cardiac event group and non-cardiac event group.
Results: During a follow-up, cardiac events was documented only in 34 of HF patients with preserved EF. Despite no difference in age, EF and 
LV diastolic volume, the cardiac events patient group had a greater washout(40.3% VS 32.3 p=0.0027) rate and a lower early HMR (1.86 VS 
2.0 p=0.041) and a lower late HMR(1.64 VS 1.89 p=0.0003) than did non-cardiac events group. Patients with late HMR<1.80 demonstrated a 
significantly greater CE rate and compared to those with HMR ≥1.80 (29.8% vs. 10.8%,; Kaplan-Meier log rank 10.78 , p=0.005).
Conclusions: Impaired cardiac sympathetic innervation assessed by MIBG is closely associated with future cardiac events in heart failure patients 
with preserved EF. Heart failure patients with preserved LVEF can be precisely risk-stratified and undergo appropriate medical management by 
assessing cardiac sympathetic nerve activity.
